作者
Janina Eden,Adam M. Thorne,Silke B. Bodewes,Damiano Patrono,Dorotea Roggio,Eva Breuer,Caterina Lonati,Daniele Dondossola,Guergana G. Panayotova,Amanda Pinter Carvalheiro da Silva Boteon,Daniel B. Walsh,Mauricio Flores Carvalho,Ivo J. Schurink,Fariha Ansari,Dagmar Kollmann,Giuliana Germinario,Elisabeth Alexis Rivas Garrido,J. Benitez,R. Rebolledo,Matteo Cescon,Matteo Ravaioli,Gabriela Berlakovich,Jeroen de Jonge,Deniz Uluk,Isabella Lurje,Georg Lurje,Yuri L. Boteon,James V. Guarrera,Renato Romagnoli,Alexander Galkin,David Meierhofer,Robert J. Porte,Pierre–Alain Clavien,Andrea Schlegel,Vincent E. de Meijer,Philipp Dutkowski
摘要
While it is currently assumed that liver assessment is only possible during normothermic machine perfusion (NMP), there is uncertainty regarding a reliable and quick prediction of graft injury during ex situ hypothermic oxygenated perfusion (HOPE). We therefore intended to test, in an international liver transplant cohort, recently described mitochondrial injury biomarkers measured during HOPE before liver transplantation.